Treatment with a low‐dose of α‐Toc decreased these HF‐induced alterations in the liver, however, this improvement was not observed with a high dose of α‐Toc treatment (Figures 1A and 1B). The gene discussed is RHBDF2; the disease is hydrops fetalis.